会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • 1-{8 {65 -O-Amino-p-halophenyl-oxy, thio or sulfinyl)-propyl{9 -4-(alkoxy or halo phenyl)piperazines
    • 1- {8- {6-(N-氨基 - 对卤代苯氧基,硫代或亚磺酰基) - 丙基{9-4(烷氧基或卤代苯基)哌嗪
    • US3925387A
    • 1975-12-09
    • US31210672
    • 1972-12-04
    • SUMITOMO CHEMICAL CO
    • MARUYAMA ISAMUNAKAO MASARUSASAJIMA KIKUOONO KEIICHITAKAYAMA MASAHARUKATAYAMA SHIGENARITANAKA YOSHIHIROYANAGIHARA IZUMIINABA SHIGEHOYAMAMOTO HISAO
    • C07D295/08A61K31/415A61K31/435A61K31/495A61P9/12A61P25/04A61P25/08A61P25/18A61P25/20C07D211/52C07D295/092C07D401/04C07D471/10C07D295/12
    • C07D295/088C07D211/52
    • WHEREIN Y is as defined above.

      WHEREIN R1, R2, R3, Z and m are as defined above and X is halogen atom, with a compound of the formula,

      (WHEREIN R4 is hydrogen or halogen atom or lower alkyl or lower alkoxy group; R5 is hydrogen atom or lower alkyl or lower alkanoyl group; R6 is hydrogen or halogen atom or lower alkyl or lower alkoxy group; R7 is hydroxy, lower alkoxy or lower alkanoyloxy group; R8 is hydrogen or halogen atom or lower alkyl, lower alkoxy or trifluoromethyl group; R9 is hydrogen atom or lower alkyl or lower alkanoyl group; R10 is hydrogen or halogen atom or lower alkyl or lower alkoxy group; and n is 0, 1 or 2); and m is an integer from 2 to 5, and pharmaceutically acceptable salts thereof, which have excellent anti-psychotonic, analgesic, anti-inflammatory and anti-hypertensive activities, are produced by reacting a compound of the formula,

      WHEREIN R1 and R2 are each hydrogen atom or lower alkyl, lower alkanoyl or aroyl group; R3 is hydrogen or halogen atom or lower alkyl or lower alkoxy group; Z is oxygen or sulfur atom or sulfinyl or sulfonyl group; Y is

      Novel alkylamine derivatives represented by the formula,
    • 由式WHEREIN R1和R2表示的新型烷基胺衍生物各自为氢原子或低级烷基,低级烷酰基或芳酰基; R3是氢或卤素原子或低级烷基或低级烷氧基; Z是氧或硫原子或亚磺酰基或磺酰基; Y为(其中R4为氢或卤素原子或低级烷基或低级烷氧基; R5为氢原子或低级烷基或低级烷酰基; R6为氢或卤素原子或低级烷基或低级烷氧基; R7为羟基,低级烷氧基 或低级烷酰氧基; R8为氢或卤素原子或低级烷基,低级烷氧基或三氟甲基; R9为氢原子或低级烷基或低级烷酰基; R10为氢或卤素原子或低级烷基或低级烷氧基; n为 0,1或2); m为2〜5的整数,及其药学上可接受的盐,其具有优异的抗心理,镇痛,抗炎和抗高血压活性,是通过使下式的化合物,即WHEREIN R1,R2,R3 ,Z和m如上所定义,X是卤素原子,与下式的化合物,其中Y如上定义。
    • 4. 发明授权
    • Butyrophenone derivatives
    • 丁酰苯衍生物
    • US3907812A
    • 1975-09-23
    • US32913073
    • 1973-02-02
    • SUMITOMO CHEMICAL CO
    • YAMAMOTO HISAOOKAMOTO TADASHISASAJIMA KIKUONAKAO MASARUMARUYAMA ISAMUKATAYAMA SHIGENARI
    • C07D211/52
    • C07D211/52Y10S514/96
    • A novel process for preparing central nervous system active butyrophenone derivatives in which gamma piperidinobutyrophenone derivatives of the formula,

      wherein R1 is hydrogen, halogen, amino, acylamino, alkylamino or N-acylalkylamino; R2 is hydrogen or halogen; R3 is hydrogen or unsubstituted or alkyl-, alkoxy-, halogen- or trifluoromethylsubstituted phenyl; and R4 is hydrogen or hydroxyl, can be prepared by reacting an indole derivative of the formula,

      wherein R2, R3 and R4 are as defined above, and R5 and R6 are each independently hydrogen or alkyl, with an oxidizing agent to yield an o-acylamino- gamma -piperidinobutyrophenone derivative of the formula,

      wherein R2, R3, R4, R5 and R6 are as defined above, and further, if necessary, hydrolyzing the product to yield an o-amino- gamma -piperidinobutyrophenone derivative of the formula,

      wherein R2, R3, R4 and R5 are as defined above, and further diazotizing, if desired, in case R5 is hydrogen, the obtained oamino- gamma -piperidinobutyrophenone derivative and subsequently decomposing the resultant diazonium compound to replace the diazonium group by hydrogen or halogen. Among the butyrophenone derivatives thus obtained, those in which R1 is halogen, amino, acylamino, alkylamino or N-acylalkylamino are novel compounds.
    • 一种用于制备中枢神经系统活性丁酰苯衍生物的新方法,其中式为CO-CH 2 -CH 2 -CH 2 -YGLE R 1的γ-哌啶基丁酰苯衍生物,其中R 1为氢,卤素,氨基,酰氨基,烷基氨基或N-酰基烷基氨基; R2是氢或卤素; R3是氢或未取代的或烷基,烷氧基,卤素或三氟甲基取代的苯基; 并且R 4是氢或羟基,可以通过使下式的吲哚衍生物CH2-CH2-CH2-ANGLE R6 | R5(其中R2,R3和R4如上定义)与R5和R6各自独立地是氢或烷基 与氧化剂反应得到下式的邻酰基氨基-γ-哌啶基丁酰苯衍生物,其中R2,R3,R4,R5和R6的定义如上所定义,CO- 此外,如果需要,水解产物以产生下式的邻氨基-γ-哌啶基丁酰苯衍生物,其中R2,R3,R4和R5如上所定义,进一步重氮化, 如果需要,在R5为氢的情况下,得到的邻氨基-γ-哌啶基丁酰苯衍生物,随后分解所得重氮化合物以用氢或卤素代替重氮基团。 在由此获得的丁酰苯衍生物中,R 1为卤素,氨基,酰氨基,烷基氨基或N-酰基烷基氨基的那些是新化合物。